[SRNE] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
19-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 14.90%
YoY- -13.82%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 12,062 13,511 14,255 11,505 11,753 9,007 7,721 34.60%
PBT -119,773 -167,340 2,212 -73,068 -86,398 -82,213 -68,900 44.52%
Tax 386 -641 -206 36 145 -1,919 -276 -
NP -119,803 -166,615 2,510 -71,502 -84,023 -77,740 -65,195 49.97%
Tax Rate - - 9.31% - - - - -
Total Cost 131,865 180,126 11,745 83,007 95,776 86,747 72,916 48.38%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -993.23 -1,233.18 17.61 -621.49 -714.91 -863.11 -844.39 11.41%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.40 -0.57 0.01 -0.28 -0.33 -0.36 -0.36 7.26%
EPS Diluted -0.40 -0.57 0.01 -0.28 -0.33 -0.36 -0.36 7.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.